BW-373U86

N/A

Report date: 2025/03/18 17:21:13

NME

Base Information

Drug NameBW-373U86

Drug Alias NameBenzamide,4-[[2,5-dimethyl-4-(2-propenyl)-1-piperazinyl](3-hydroxyphenyl)methyl]-N,N-diethyl-, [1(S*),2.alpha.,5.beta.]-(.+-.)-BW-373U86

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of Actionδ-opioid receptor agonists

Targetsδ-opioid receptor

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBurroughs Wellcome

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBurroughs Wellcome

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A